Nonselective TRPC channel inhibition and suppression of aminoglycoside-induced premature termination codon readthrough by the small molecule AC1903

• Published in: The Journal of biological chemistry 2022-02, Vol.298 (2), p.101546, Article 101546
• Main Authors: Baradaran-Heravi, Alireza, Bauer, Claudia C., Pickles, Isabelle B., Hosseini-Farahabadi, Sara, Balgi, Aruna D., Choi, Kunho, Linley, Deborah M., Beech, David J., Roberge, Michel, Bon, Robin S.
• Format: Article
• Language: English
• Subjects: AC1903; aminoglycoside; Aminoglycosides - pharmacology; Codon, Nonsense - drug effects; G418; genetic disease; Humans; Indazoles - pharmacology; ion channel; Pico145; premature termination codon readthrough; Protein Synthesis Inhibitors; translation; TRP channel; TRPC Cation Channels - antagonists & inhibitors; TRPC Cation Channels - genetics; TRPC Cation Channels - metabolism
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/j.jbc.2021.101546

Nonsense mutations, which occur in ∼11% of patients with genetic disorders, introduce premature termination codons (PTCs) that lead to truncated proteins and promote nonsense-mediated mRNA decay. Aminoglycosides such as G418 permit PTC readthrough and so may be used to address this problem. However, their effects are variable between patients, making clinical use of aminoglycosides challenging. In this study, we tested whether TRPC nonselective cation channels contribute to the variable PTC readthrough effect of aminoglycosides by controlling their cellular uptake. Indeed, a recently reported selective TRPC5 inhibitor, AC1903, consistently suppressed G418 uptake and G418-induced PTC readthrough in the DMS-114 cancer cell line and junctional epidermolysis bullosa (JEB) patient-derived keratinocytes. Interestingly, the effect of AC1903 in DMS-114 cells was mimicked by nonselective TRPC inhibitors, but not by well-characterized inhibitors of TRPC1/4/5 (Pico145, GFB-8438) or TRPC3/6/7 (SAR7334), suggesting that AC1903 may work through additional or undefined targets. Indeed, in our experiments, AC1903 inhibited multiple TRPC channels including TRPC3, TRPC4, TRPC5, TRPC6, TRPC4–C1, and TRPC5–C1, as well as endogenous TRPC1:C4 channels in A498 renal cancer cells, all with low micromolar IC50 values (1.8–18 μM). We also show that AC1903 inhibited TRPV4 channels, but had weak or no effects on TRPV1 and no effect on the nonselective cation channel PIEZO1. Our study reveals that AC1903 has previously unrecognized targets, which need to be considered when interpreting results from experiments with this compound. In addition, our data strengthen the hypothesis that nonselective calcium channels are involved in aminoglycoside uptake.